Reduction of Surgical Site Infection in Cardiac Surgery using a Microbial Sealant-A Controlled Study

Phase 2

Completed

• Conditions: Surgical Site Infection; Surgery - Surgical techniques; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12610000743066
• Lead Sponsor: Ian Gilfillan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Isolated Coronary Artery bypass patients requiring greater than 2 lengths of saphenous vein conduit.

Exclusion Criteria

Peripheral vascular disease, long saphenous vein abnormality, leg skin lesions or ulcers, prior sensitivity to cyanoacrlate, acetone or formaldehyde containg products, non consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound infection, scored by blinded observors according to Southampton wound score system[At 1 month following surgery]

Secondary Outcome Measures

Name	Time	Method
wound swab microbial culture[At 5 days post operatively.]